Nantz National Alzheimer Center, Houston Methodist Research Institute, and Weill Cornell Medicine, Houston, Texas
Nantz National Alzheimer Center, Houston Methodist Research Institute, and Weill Cornell Medicine, Houston, Texas.
J Nucl Med. 2018 Aug;59(8):1260-1266. doi: 10.2967/jnumed.117.203109. Epub 2018 Jan 18.
F-GE180 is a third-generation PET tracer for quantifying the translocator protein (TSPO), a biomarker for inflammation. The aim of this study was to perform a head-to-head comparison of F-GE180 and the well-established TSPO tracer C-PBR28 by scanning with both tracers during the same day in the same subjects. Five subjects underwent a 90-min PET scan with C-PBR28 in the morning and F-GE180 in the afternoon. A metabolite-corrected arterial input function was obtained in each subject for both tracers, and the brain uptake was quantified with a 2-tissue-compartment model. The rate of metabolism of F-GE180 in arterial blood was slower than that of C-PBR28 (the percentages of nonmetabolized parent in plasma at 90 min were 74.9% ± 4.15% [mean ± SD] and 11.2% ± 1.90%, respectively). The plasma free fractions were similar for both tracers: 3.5% ± 1.1% for F-GE180 and 4.1% ± 1.1% for C-PBR28. The average total volume of distribution () of F-GE180 was about 20 times smaller than that of C-PBR28 (0.15 ± 0.03 mL/cm for F-GE180 and 3.27 ± 0.66 mL/cm for C-PBR28). F-GE180 was characterized by poor transfer from the vascular compartment to the brain (its plasma-to-tissue rate constant [K] was about 10 times smaller than that of C-PBR28). Moreover, kinetic modeling was more difficult with F-GE180, as its values were identified with a lower precision than those of C-PBR28 and outlying values were more frequent. The of F-GE180 was about 20 times smaller than that of C-PBR28 because of low penetration into the brain from the vascular compartment. In addition, kinetic modeling of F-GE180 was more challenging than that of C-PBR28. Therefore, compared with C-PBR28, F-GE180 had unfavorable characteristics for TSPO imaging of the brain.
F-GE180 是一种第三代正电子发射断层扫描(PET)示踪剂,用于定量检测转位蛋白(TSPO),TSPO 是炎症的生物标志物。本研究旨在通过在同一天的同一批受试者中同时使用这两种示踪剂进行头对头比较,以评估 F-GE180 与成熟的 TSPO 示踪剂 C-PBR28 的性能。五名受试者在上午进行了 90 分钟的 C-PBR28 PET 扫描,下午进行了 F-GE180 扫描。每位受试者都获得了两种示踪剂的校正代谢物的动脉输入函数,并使用 2 组织室模型定量了脑摄取。F-GE180 在动脉血中的代谢率比 C-PBR28 慢(90 分钟时未代谢母体的百分比分别为 74.9%±4.15%[平均值±标准差]和 11.2%±1.90%)。两种示踪剂的血浆游离分数相似:F-GE180 为 3.5%±1.1%,C-PBR28 为 4.1%±1.1%。F-GE180 的平均总分布容积(Vd)约为 C-PBR28 的 20 倍(F-GE180 为 0.15±0.03mL/cm,C-PBR28 为 3.27±0.66mL/cm)。F-GE180 从血管腔向大脑的转移较差(其血浆-组织速率常数[K]约为 C-PBR28 的 10 倍)。此外,F-GE180 的动力学建模更具挑战性,因为其 Vd 值的确定精度低于 C-PBR28,并且出现了更多的异常值。由于从血管腔向大脑的穿透率低,F-GE180 的 Vd 约为 C-PBR28 的 20 倍。此外,F-GE180 的动力学建模比 C-PBR28 更具挑战性。因此,与 C-PBR28 相比,F-GE180 用于大脑 TSPO 成像具有不利的特征。